IMWG Conference Series: ASH 2020
click on the image above to view the video
View Slides
The IMWG Conference Series Outlines Myeloma News and Trends From the 2020 Annual ASH Meeting
Patients, caregivers, and doctors around the world can view the IMF's popular livestream IMWG Conference Series from ASH 2020.
Dr. Brian G.M. Durie, Dr. Joseph Mikhael, Dr. Maria V. Mateos, and Dr. Thomas Martin distill, debate, and discuss the latest news and trends in the treatment of multiple myeloma from the 62nd Annual American Society of Hematology Meeting.
Topics include:
- Smoldering myeloma
- Frontline therapy
- Early relapse
- Key new role of immune therapies
- Future directions
with an educational grant from:
Amgen Oncology, Janssen Oncology, Karyopharm Therapeutics, Oncopeptides, Sanofi Genzyme, and Takeda Oncology
Previous Post
A Phase 1 Study of AMG 701 in Subjects With Relapsed/Refractory Multiple Myeloma
Next Post
Impact of Imaging FDG-PET/CT Minimal Residual Disease Assessment in Newly Diagnosed Transplant Eligible Multiple Myeloma Patients